Acceptability and satisfaction of project MOVE: A pragmatic feasibility trial aimed at increasing physical activity in female breast cancer survivors

por Pullen, Tanya, Sharp, Paul, Bottorff, Joan L., Sabiston, Catherine M., Campbell, Kristin L., Ellard, Susan L., Gotay, Carolyn, Fitzpatrick, Kayla, Caperchione, Cristina M.
Publicado 2018

Innovative approach for increasing physical activity among breast cancer survivors: protocol for Project MOVE, a quasi-experimental study

por Caperchione, Cristina M, Sabiston, Catherine M, Clark, Marianne I, Bottorff, Joan L, Toxopeus, Renee, Campbell, Kristin L, Eves, Neil D, Ellard, Susan L, Gotay, Carolyn
Publicado 2016

A preliminary trial examining a ‘real world’ approach for increasing physical activity among breast cancer survivors: findings from project MOVE

por Caperchione, Cristina M., Sabiston, Catherine M., Stolp, Sean, Bottorff, Joan L., Campbell, Kristin L., Eves, Neil D., Ellard, Susan L., Gotay, Carolyn, Sharp, Paul, Pullen, Tanya, Fitzpatrick, Kayla M.
Publicado 2019

A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER...

por Chia, Stephen K., Ellard, Susan L., Mates, Mihaela, Welch, Stephen, Mihalcioiu, Catalin, Miller, Wilson H., Gelmon, Karen, Lohrisch, Caroline, Kumar, Vikaash, Taylor, Sara, Hagerman, Linda, Goodwin, Rachel, Wang, Tao, Sakashita, Shingo, Tsao, Ming S., Eisenhauer, Elizabeth, Bradbury, Penelope
Publicado 2017

What if the future of HER2‐positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study

por Pizzamiglio, Sara, Cosentino, Giulia, Ciniselli, Chiara M., De Cecco, Loris, Cataldo, Alessandra, Plantamura, Ilaria, Triulzi, Tiziana, El‐abed, Sarra, Wang, Yingbo, Bajji, Mohammed, Nuciforo, Paolo, Huober, Jens, Ellard, Susan L., Rimm, David L., Gombos, Andrea, Daidone, Maria Grazia, Verderio, Paolo, Tagliabue, Elda, Di Cosimo, Serena, Iorio, Marilena V.
Publicado 2021

Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers

por Stany, Michael P., Vathipadiekal, Vinod, Ozbun, Laurent, Stone, Rebecca L., Mok, Samuel C., Xue, Hui, Kagami, Takashi, Wang, Yuwei, McAlpine, Jessica N., Bowtell, David, Gout, Peter W., Miller, Dianne M., Gilks, C. Blake, Huntsman, David G., Ellard, Susan L., Wang, Yu-Zhuo, Vivas-Mejia, Pablo, Lopez-Berestein, Gabriel, Sood, Anil K., Birrer, Michael J.
Publicado 2011

Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5–13/TESARO PR-30–50–10-C BRAVO Study

por Turner, Nicholas C., Balmaña, Judith, Poncet, Coralie, Goulioti, Theodora, Tryfonidis, Konstantinos, Honkoop, Aafke H., Zoppoli, Gabriele, Razis, Evangelia, Johannsson, Oskar T., Colleoni, Marco, Tutt, Andrew N., Audeh, William, Ignatiadis, Michail, Mailliez, Audrey, Trédan, Olivier, Musolino, Antonino, Vuylsteke, Peter, Juan-Fita, Maria Jose, Macpherson, Iain R.J., Kaufman, Bella, Manso, Luis, Goldstein, Lori J., Ellard, Susan L., Láng, István, Jen, Kai Yu, Adam, Virginie, Litière, Saskia, Erban, John, Cameron, David A.
Publicado 2021